Eli Lilly and Novo Nordisk stocks fall as Trump says he wants $150 price for GLP-1s
1. Trump aims to cut GLP-1 drug prices to $150 monthly. 2. Eli Lilly shares fell 2% in response to the news. 3. Current pricing for GLP-1s competitive among compounded options. 4. Only 20% of large employers offer GLP-1 weight loss drugs. 5. Drug pricing negotiations are still ongoing with the administration.